Clinical Trial

Risk and Prognosis of Brain Metastasis in Non-Small Cell Lung Cancer

Not Yet Recruiting

Summary

This multi-center, prospective, observational study aim to construct a comprehensive model, integrating common clinical pathological parameters, radiographic features and multi-omics data, for assessing the risk and prognosis of brain metastasis in NSCLC. This model is intended to address the following clinical needs: (1) Identify patients at high risk of brain metastasis; (2) Optimize the combined strategies of local and systemic treatments; (3) Predict the survival outcomes of patients with brain metastases from NSCLC and provide evidence-based support for individualized treatment decisions.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-06-15.

Trial Details

NCT Number	NCT07034365
Lead Sponsor	Fudan University
Conditions	NSCLC (Non-small Cell Lung Cancer), Brain Metastases From Non-small Cell Lung Cancer (NSCLC)
Enrollment	2,000 participants
Start Date	2025-08
Primary Completion	2026-12 (estimated)
Study Completion	2027-05 (estimated)
Updated on ClinicalTrials.gov	2025-06-29